# FDA Inspection 1123839 - PolyCrystalLine SpA - May 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/polycrystalline-spa/09075725-81e0-4491-8ea7-d0e2ee93564f
Source feed: FDA_Inspections

> FDA Inspection 1123839 for PolyCrystalLine SpA on May 22, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1123839
- Company Name: PolyCrystalLine SpA
- Inspection Date: 2019-05-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1288704 - 2023-10-20](https://www.keypedia.com/records/fda_inspections/polycrystalline-spa/77193b49-d031-47e7-a6c8-137541b7d292)

Company: https://www.keypedia.com/companies/polycrystalline-spa/b76b2ab4-6e9d-4cee-9b43-21c12abd68ec

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c